2012
DOI: 10.1556/aphysiol.99.2012.1.8
|View full text |Cite
|
Sign up to set email alerts
|

Effect ofm-3m3FBS on Ca2+handling and viability in OC2 human oral cancer cells

Abstract: The effect of 2,4,6-trimethyl-N-(meta-3-trifluoromethyl-phenyl)-benzenesulfonamide (m-3M3FBS), a presumed phospholipase C activator, on cytosolic free Ca2+ concentrations ([Ca2+]i) in OC2 human oral cancer cells is unclear. This study explored whether m-3M3FBS changed basal [Ca2+]i levels in suspended OC2 cells by using fura-2 as a Ca2+-sensitive fluorescent dye. M-3M3FBS at concentrations between 10-60 μM increased [Ca2+]i in a concentration-dependent manner. The Ca2+ signal was reduced partly by removing ext… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…To deplete the ER-Ca 2+ stores, cells were perfused with the reversible Ca 2+ -ATPase (SERCA) inhibitor cyclopiazonic acid-CPA (20 μM, Sigma-Aldrich, USA), followed by the addition of mibefradil 100 μM in Ca 2+ -free Ringer's solution. To address the role of the PLC isoenzymes, cells were perfused with the PLC activator m-3M3FBS (60 μM) (Sigma-Aldrich, USA) as reported [47] followed by the addition of mibefradil 100 μM in regular extracellular Ca 2+ levels (2 mM Ca 2+ ). We also use the PLC blocker U73122 (5 μM) (Sigma-Aldrich, USA) simultaneously with the application of mibefradil (100 μM) [48].…”
Section: Pharmacology and Extracellular Ca 2+ Conditionsmentioning
confidence: 99%
“…To deplete the ER-Ca 2+ stores, cells were perfused with the reversible Ca 2+ -ATPase (SERCA) inhibitor cyclopiazonic acid-CPA (20 μM, Sigma-Aldrich, USA), followed by the addition of mibefradil 100 μM in Ca 2+ -free Ringer's solution. To address the role of the PLC isoenzymes, cells were perfused with the PLC activator m-3M3FBS (60 μM) (Sigma-Aldrich, USA) as reported [47] followed by the addition of mibefradil 100 μM in regular extracellular Ca 2+ levels (2 mM Ca 2+ ). We also use the PLC blocker U73122 (5 μM) (Sigma-Aldrich, USA) simultaneously with the application of mibefradil (100 μM) [48].…”
Section: Pharmacology and Extracellular Ca 2+ Conditionsmentioning
confidence: 99%
“…m-3M3FBS treatment can overcome the anti-apoptotic effect of Bcl-2 or c-FLIPs in cancer cells [18]. m-3M3FBS also induces Ca 2+ -independent cell death and apoptosis [19,20]. This compound provides an opportunity to study PLC-mediated signaling.…”
Section: Introductionmentioning
confidence: 99%